CURIS INC 8-K

What Happened
Curis, Inc. (CRIS) announced that at its May 19, 2026 annual meeting stockholders approved and the company filed a Certificate of Amendment increasing total authorized capital stock from 288,757,150 to 572,514,300 shares and authorized common stock from 283,757,150 to 567,514,300 shares (effective upon filing). On the same date Curis filed a Certificate of Elimination removing the Series A Convertible Exchangeable Preferred Stock and Series B Convertible Non‑Redeemable Preferred Stock designations; those shares returned to being undesignated, authorized but unissued preferred stock. The company filed the 8‑K on May 22, 2026.

Key Details

• Authorized common shares increased from 283,757,150 to 567,514,300; total authorized capital stock increased from 288,757,150 to 572,514,300.
• Certificates were filed with the Delaware Secretary of State and were effective upon filing on May 19, 2026.
• Series A and Series B preferred designations were eliminated; the former series shares are now undesignated, authorized but unissued preferred stock.
• Annual meeting votes: Proposal to amend charter (Proposal 4) passed — For: 21,649,122; Against: 1,768,174; Abstain: 192,082. Directors Martyn D. Greenacre and Kenneth I. Kaitin, Ph.D. were re‑elected; PricewaterhouseCoopers LLP was ratified as auditor.

Why It Matters
Increasing authorized shares gives Curis’ board flexibility to issue additional common stock or preferred shares in the future (for fundraising, acquisitions, equity compensation, etc.), which can dilute existing shareholders if and when new shares are issued. Eliminating the Series A/B designations simplifies the preferred share structure by returning those shares to undesignated preferred status. The filing does not announce any immediate share issuances — investors should watch future SEC filings (e.g., 8-Ks, S-3/10 filings) for any planned issuances or financings.